References
- 1BuijinkAWvan der StouweAMBroersmaMet alMotor network disruption in essential tremor: A functional and effective connectivity studyBrain201513829342947doi: http://dx.doi.org/10.1093/brain/awv22526248468
- 2Erickson-DavisCRFaustPLVonsattelJPGuptaSHonigLSLouisED“Hairy baskets” associated with degenerative Purkinje cell changes in essential tremorJ Neuropathol Exp Neurol201069262271doi: http://dx.doi.org/10.1097/NEN.0b013e3181d1ad0420142764
- 3RajputAHAdlerCHShillHARajputAEssential tremor is not a neurodegenerative diseaseNeurodegener Dis Manag20122259268doi: http://dx.doi.org/10.2217/nmt.12.2323105950
- 4ShillHAAdlerCHSabbaghMNet alPathologic findings in prospectively ascertained essential tremor subjectsNeurology20087014521455doi: http://dx.doi.org/10.1212/01.wnl.0000310425.76205.0218413570
- 5SymanskiCShillHADuggerBet alEssential tremor is not associated with cerebellar Purkinje cell lossMov Disord201429496500doi: http://dx.doi.org/10.1002/mds.2584524532134
- 6MallyJBaranyiMViziESChange in the concentrations of amino acids in CSF and serum of patients with essential tremorJ Neural Transm19961035555608811501
- 7ShillHAAdlerCHBeachTGet alBrain biochemistry in autopsied patients with essential tremorMov Disord201227113117doi: http://dx.doi.org/10.1002/mds.2400422038525
- 8FruchtSJHoughtonWCBordelonYGreenePELouisEDA single-blind, open-label trial of sodium oxybate for myoclonus and essential tremorNeurology2005651967196916382538
- 9NahabFBWittevrongelLIppolitoDet alAn open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremorNeurotherapeutics20118753762doi: http://dx.doi.org/10.1007/s13311-011-0045-121594724
- 10TeravainenHHuttunenJLewittPIneffective treatment of essential tremor with an alcohol, methylpentynolJ Neurol Neurosurg Psychiatry1986491981993512778
- 11HopfnerFErhartTKnudsenKet alTesting for alcohol sensitivity of tremor amplitude in a large cohort with essential tremorParkinsonism Relat Disord201521848851doi: http://dx.doi.org/10.1016/j.parkreldis.2015.05.00526002382
- 12MostileGJankovicJAlcohol in essential tremor and other movement disordersMov Disord20102522742284doi: http://dx.doi.org/10.1002/mds.2324020721919
- 13KollerWCBiaryNEffect of alcohol on tremors: Comparison with propranololNeurology198434221222doi: http://dx.doi.org/10.1212/WNL.34.2.2216538013
- 14ZeunerKEMolloyFMShogeROGoldsteinSRWesleyRHallettMEffect of ethanol on the central oscillator in essential tremorMov Disord20031812801285doi: http://dx.doi.org/10.1002/mds.1055314639668
- 15BoeckerHWillsAJCeballos-BaumannAet alThe effect of ethanol on alcohol-responsive essential tremor: A positron emission tomography studyAnn Neurol199639650658doi: http://dx.doi.org/10.1002/ana.4103905158619551
- 16GrowdonJHShahaniBTYoungRRThe effect of alcohol on essential tremorNeurology197525259doi: http://dx.doi.org/10.1212/WNL.25.3.2591167633
- 17LeznikELlinasRRole of gap junctions in synchronized neuronal oscillations in the inferior oliveJ Neurophysiol2005942447245615928056
- 18AdermarkLOlssonTHanssonEEthanol acutely decreases astroglial gap junction permeability in primary cultures from defined brain regionsNeurochem Int200445971978doi: http://dx.doi.org/10.1016/j.neuint.2004.06.00715337295
- 19MustonenHKiviluotoTPaimelaHPuolakkainenPKivilaaksoECalcium signaling is involved in ethanol induced volume decrease and gap junction closure in cultured rat gastric mucosal cellsDig Dis Sci200550103110doi: http://dx.doi.org/10.1007/s10620-005-1286-915712646
- 20WentlandtKKushnirMNausCCCarlenPLEthanol inhibits gap-junctional coupling between P19 cellsAlcohol Clin Exp Res20042812841290doi: http://dx.doi.org/10.1097/01.ALC.0000139705.17646.BA15365297
- 21SinclairJGLoGFHarrisDPEthanol effects on the olivocerebellar systemCan J Physiol Pharmacol198260610614doi: http://dx.doi.org/10.1139/y82-0827104848
- 22MameliMBottaPZamudioPAZuccaSValenzuelaCFEthanol decreases Purkinje neuron excitability by increasing GABA release in rat cerebellar slicesJ Pharmacol Exp Ther2008327910917doi: http://dx.doi.org/10.1124/jpet.108.14486518755936
- 23KumarSPorcuPWernerDFet alThe role of GABA(A) receptors in the acute and chronic effects of ethanol: A decade of progressPsychopharmacology2009205529564doi: http://dx.doi.org/10.1007/s00213-009-1562-z19455309
- 24OlsenRWSieghartWGABA A receptors: Subtypes provide diversity of function and pharmacologyNeuropharmacology200956141148doi: http://dx.doi.org/10.1016/j.neuropharm.2008.07.04518760291
- 25ZheleznovaNNSedelnikovaAWeissDSFunction and modulation of delta-containing GABA(A) receptorsPsychoneuroendocrinology200934Suppl. 1S67S73doi: http://dx.doi.org/10.1016/j.psyneuen.2009.08.01019766404
- 26SankarRGABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazamCNS Drugs201226229244doi: http://dx.doi.org/10.2165/11599020-000000000-0000022145708
- 27GironellAThe GABA hypothesis in essential tremor: lights and shadowsTremor Other Hyperkinet Mov (NY20144doi: http://dx.doi.org/10.7916/D8SF2T9C
- 28WakitaMShinMCIwataSNonakaKAkaikeNEffects of ethanol on GABA(A) receptors in GABAergic and glutamatergic presynaptic nerve terminalsJ Pharmacol Exp Ther2012341809819doi: http://dx.doi.org/10.1124/jpet.111.18912622434676
- 29KelmMKCriswellHEBreeseGREthanol-enhanced GABA release: A focus on G protein-coupled receptorsBrain Res Rev201165113123doi: http://dx.doi.org/10.1016/j.brainresrev.2010.09.00320837058
- 30CushmanJDMooreMDJacobsNSOlsenRWFanselowMSBehavioral pharmacogenetic analysis on the role of the alpha4 GABA(A) receptor subunit in the ethanol-mediated impairment of hippocampus-dependent contextual learningAlcohol Clin Exp Res20113519481959doi: http://dx.doi.org/10.1111/j.1530-0277.2011.01546.x21943327
- 31GlykysJPengZChandraDHomanicsGEHouserCRModyIA new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanolNat Neurosci2007104048doi: http://dx.doi.org/10.1038/nn181317159992
- 32MihalekRMBowersBJWehnerJMet alGABA(A)-receptor delta subunit knockout mice have multiple defects in behavioral responses to ethanolAlcohol Clin Exp Res2001251708171811781502
- 33WeiWFariaLCModyILow ethanol concentrations selectively augment the tonic inhibition mediated by delta subunit-containing GABAA receptors in hippocampal neuronsJ Neurosci20042483798382doi: http://dx.doi.org/10.1523/JNEUROSCI.2040-04.200415385620
- 34MantoMLauteMAA possible mechanism for the beneficial effect of ethanol in essential tremorEur J Neurol200815697705doi: http://dx.doi.org/10.1111/j.1468-1331.2008.02150.x18445025
- 35ShahidullahMHarrisTGermannMWCovarrubiasMMolecular features of an alcohol binding site in a neuronal potassium channelBiochemistry2003421124311252doi: http://dx.doi.org/10.1021/bi034738f14503874
- 36de HaasSLZoethoutRWVan DyckKet alThe effects of TPA023, a GABAAalpha2,3 subtype-selective partial agonist, on essential tremor in comparison to alcoholJ Psychopharmacol201226282291doi: http://dx.doi.org/10.1177/026988111141573121890585
- 37GreenfieldLJ
Jr Molecular mechanisms of antiseizure drug activity at GABAA receptorsSeizure201322589600doi: http://dx.doi.org/10.1016/j.seizure.2013.04.01523683707 - 38SassoEPeruccaECalzettiSDouble-blind comparison of primidone and phenobarbital in essential tremorNeurology198838808808doi: http://dx.doi.org/10.1212/WNL.38.5.8083283599
- 39KollerWCRoyseVLEfficacy of primidone in essential tremorNeurology198636121124doi: http://dx.doi.org/10.1212/WNL.36.1.1213941767
- 40CalzettiSFindleyLJPisaniFRichensAPhenylethylmalonamide in essential tremor. A double-blind controlled studyJ Neurol Neurosurg Psychiatry1981449329347031184
- 41GironellAMartinez-CorralMPagonabarragaXKulisevskyJTiagabine for essential tremor: An open-label trialMov Disord20082319551956doi: http://dx.doi.org/10.1002/mds.2209418759354
- 42ZesiewiczTASullivanKLWardCLHauserRATiagabine and exacerbation of essential tremorMov Disord20072221322133doi: http://dx.doi.org/10.1002/mds.2155917663461
- 43WalkerSDKalviainenRNon-vision adverse events with vigabatrin therapyActa Neurol Scand20111247282doi: http://dx.doi.org/10.1111/j.1600-0404.2011.01602.x
- 44MondrupKDupontEPedersenEThe effect of the GABA-agonist, progabide, on benign essential tremor. A controlled clinical trialActa Neurol Scand198368248252doi: http://dx.doi.org/10.1111/j.1600-0404.1983.tb04833.x6362317
- 45KollerWCRubinoFGuptaSPharmacologic probe with progabide of GABA mechanisms in essential tremorArch Neurol1987449059563619708
- 46PahapillPALevyRDostrovskyJOet alTremor arrest with thalamic microinjections of muscimol in patients with essential tremorAnn Neurol199946249252doi: http://dx.doi.org/10.1002/1531-8249(199908)46:2<249::AID-ANA15>3.0.CO;2-C10443891
- 47FruchtSJBordelonYHoughtonWHReardanDA pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disordersMov Disord20052013301337doi: http://dx.doi.org/10.1002/mds.2060515986420
- 48LiQKuhnCMWilsonWALewisDVEffects of gamma hydroxybutyric acid on inhibition and excitation in rat neocortexNeuroscience20071508292doi: http://dx.doi.org/10.1016/j.neuroscience.2007.08.02317904295
- 49WeissNNorthRBOharaSLenzFAAttenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: The role of gamma-aminobutyric acidergic pathways. Case reportJ Neurosurg200399768771doi: http://dx.doi.org/10.3171/jns.2003.99.4.076814567614
- 50BusenbarkKPahwaRHubbleJKollerWThe effect of acetazolamide on essential tremor: An open-label trialNeurology19924213941394doi: http://dx.doi.org/10.1212/WNL.42.7.13941620352
- 51GunalDIAfsarNBekirogluNAktanSNew alternative agents in essential tremor therapy: Double-blind placebo-controlled study of alprazolam and acetazolamideNeurol Sci200021315317doi: http://dx.doi.org/10.1007/s10072007006911286044
- 52BusenbarkKPahwaRHubbleJHopfenspergerKKollerWPogrebraKDouble-blind controlled study of methazolamide in the treatment of essential tremorNeurology19934310451047doi: http://dx.doi.org/10.1212/WNL.43.5.10458492925
- 53BusenbarkKRamigLDromeyCKollerWCMethazolamide for essential voice tremorNeurology19964713311332doi: http://dx.doi.org/10.1212/WNL.47.5.13318909454
- 54OndoWHunterCVuongKDSchwartzKJankovicJGabapentin for essential tremor: A multiple-dose, double-blind, placebo-controlled trialMov Disord200015678682doi: http://dx.doi.org/10.1002/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-010928578
- 55PahwaRLyonsKHubbleJPet alDouble-blind controlled trial of gabapentin in essential tremorMov Disord199813465467doi: http://dx.doi.org/10.1002/mds.8701303159613738
- 56ZesiewiczTASullivanKLHinsonVet alMultisite, double-blind, randomized, controlled study of pregabalin for essential tremorMov Disord201328249250doi: http://dx.doi.org/10.1002/mds.2526423238907
- 57FerraraJMKenneyCDavidsonALShinawiLKisselAMJankovicJEfficacy and tolerability of pregabalin in essential tremor: A randomized, double-blind, placebo-controlled, crossover trialJ Neurol Sci2009285195197doi: http://dx.doi.org/10.1016/j.jns.2009.06.04419631949
- 58GironellAKulisevskyJBarbanojMLopez-VillegasDHernandezGPascual-SedanoBA randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremorArch Neurol199956475480doi: http://dx.doi.org/10.1001/archneur.56.4.47510199338
- 59BusharaKOMalikTExcondeREThe effect of levetiracetam on essential tremorNeurology20056410781080doi: http://dx.doi.org/10.1212/01.WNL.0000154596.21335.2E15781835
- 60OndoWGJimenezJEVuongKDJankovicJAn open-label pilot study of levetiracetam for essential tremorClin Neuropharmacol200427274277doi: http://dx.doi.org/10.1097/00002826-200411000-0000415613931
- 61Mendoza-TorreblancaJGVanoye-CarloAPhillips-FarfanBVCarmona-AparicioLGomez-LiraGSynaptic vesicle protein 2A: Basic facts and role in synaptic functionEur J Neurosci20133835293539doi: http://dx.doi.org/10.1111/ejn.1236024102679
- 62HandforthABordelonYFruchtSJQuesadaAA pilot efficacy and tolerability trial of memantine for essential tremorClin Neuropharmacol201033223226doi: http://dx.doi.org/10.1097/WNF.0b013e3181ebd10920838216
- 63GironellAKulisevskyJPascual-SedanoBFlamarichDEffect of amantadine in essential tremor: A randomized, placebo-controlled trialMov Disord20062144144516229019
- 64HandforthAHomanicsGECoveyDFet alT-type calcium channel antagonists suppress tremor in two mouse models of essential tremorNeuropharmacology201059380387doi: http://dx.doi.org/10.1016/j.neuropharm.2010.05.01220547167
- 65MiwaHKohJKajimotoYKondoTEffects of T-type calcium channel blockers on a parkinsonian tremor model in ratsPharmacol Biochem Behav201197656659doi: http://dx.doi.org/10.1016/j.pbb.2010.11.01421112351
- 66MitsudaMNomotoMIwataSEffects of beta-blockers and nicardipine on oxotremorine-induced tremor in common marmosetsJpn J Pharmacol199981244246doi: http://dx.doi.org/10.1254/jjp.81.24410591485
- 67LeighPNJeffersonDTwomeyAMarsdenCDBeta-adrenoreceptor mechanisms in essential tremor; A double-blind placebo controlled trial of metoprolol, sotalol and atenololJ Neurol Neurosurg Psychiatry1983467107156310053
- 68ZoethoutRWIannoneRBloemBRet alThe effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcoholJ Psychopharmacol201226292302doi: http://dx.doi.org/10.1177/026988111139868521335358
- 69LeeKSKimJSKimJWLeeWYJeonBSKimDA multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremorParkinsonism Relat Disord20039341347doi: http://dx.doi.org/10.1016/S1353-8020(03)00029-412853233
- 70SongIUHaSWYangYSChungYADifferences in regional glucose metabolism of the brain measured with F-18-FDG-PET in patients with essential tremor according to their response to beta-blockersKorean J Radiol201516967972doi: http://dx.doi.org/10.3348/kjr.2015.16.5.96726357492
- 71KollerWCBiaryNMetoprolol compared with propranolol in the treatment of essential tremorArch Neurol198441171172doi: http://dx.doi.org/10.1001/archneur.1984.040501400690266691818
- 72CalzettiSFindleyLJGrestyMAPeruccaERichensAMetoprolol and propranolol in essential tremor: A double-blind, controlled studyJ Neurol Neurosurg Psychiatry1981448148197031187
- 73JeffersonDWharradHJBirminghamATPatrickJMThe comparative effects of ICI 118551 and propranolol on essential tremorBr J Clin Pharmacol1987247297342894217
- 74KollerWOrebaughCLawsonLPotempaKPindolol-induced tremorClin Neuropharmacol198710449452doi: http://dx.doi.org/10.1097/00002826-198710000-000073332615
- 75KralicJECriswellHEOstermanJLet alGenetic essential tremor in gamma-aminobutyric acid A receptor alpha1 subunit knockout miceJ Clin Invest200511577477915765150
- 76MartinFCThu LeAHandforthAHarmaline-induced tremor as a potential preclinical screening method for essential tremor medicationsMov Disord200520298305doi: http://dx.doi.org/10.1002/mds.2033115580562
- 77PatersonNEMalekianiSAForemanMMOlivierBHananiaTPharmacological characterization of harmaline-induced tremor activity in miceEur J Pharmacol20096167380doi: http://dx.doi.org/10.1016/j.ejphar.2009.05.03119497322
- 78HandforthAHarmaline tremor: Underlying mechanisms in a potential animal model of essential tremorTremor Other Hyperkinet Mov (N Y)20122doi: http://dx.doi.org/10.7916/D8TD9W2P
- 79MartinFCHandforthACarbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremorMov Disord20062116411649doi: http://dx.doi.org/10.1002/mds.2094016773639
